These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15796069)

  • 1. [Study of Parkinson's disease-causing mechanism and development of anti-Parkinson's disease drugs using endogenous substances in brain].
    Ohta S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Feb; 25(1):39-42. PubMed ID: 15796069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson's Disease.
    Wąsik A; Romańska I; Michaluk J; Zelek-Molik A; Nalepa I; Antkiewicz-Michaluk L
    Neurotox Res; 2016 Apr; 29(3):351-63. PubMed ID: 26303030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF.
    Kotake Y; Tasaki Y; Makino Y; Ohta S; Hirobe M
    J Neurochem; 1995 Dec; 65(6):2633-8. PubMed ID: 7595560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain.
    Yamakawa T; Kotake Y; Fujitani M; Shintani H; Makino Y; Ohta S
    Neurosci Lett; 1999 Nov; 276(1):68-70. PubMed ID: 10586977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Effects of Acute and Chronic Administration of Tetrahydroisoquinoline Amines on the In Vivo Dopamine Release: A Microdialysis Study in the Rat Striatum.
    Wąsik A; Romańska I; Antkiewicz-Michaluk L
    Neurotox Res; 2016 Nov; 30(4):648-657. PubMed ID: 27568335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous risk factors in Parkinson's disease: dopamine and tetrahydroisoquinolines.
    Antkiewicz-Michaluk L
    Pol J Pharmacol; 2002; 54(6):567-72. PubMed ID: 12866710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tetrahydroisoquinolines in connection with Parkinson's disease].
    Ohta S
    Rinsho Shinkeigaku; 1989 Dec; 29(12):1504-6. PubMed ID: 2698297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on cultured rat mesencephalic neurons in the presence or absence of various neurotoxins.
    Kotake Y; Taguchi R; Okuda K; Sekiya Y; Tasaki Y; Hirobe M; Ohta S
    Brain Res; 2005 Feb; 1033(2):143-50. PubMed ID: 15694918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tetrahydroisoquinoline derivatives as possible Parkinson's disease-inducing substances].
    Kotake Y
    Yakugaku Zasshi; 2002 Nov; 122(11):975-82. PubMed ID: 12440154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deprenyl decreases an endogenous parkinsonism-inducing compound, 1-benzyl-1,2,3,4-tetrahydroisoquinoline in mice: in vivo and in vitro studies.
    Kotake Y; Tasaki Y; Hirobe M; Ohta S
    Brain Res; 1998 Mar; 787(2):341-3. PubMed ID: 9518683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.
    Kikuchi K; Nagatsu Y; Makino Y; Mashino T; Ohta S; Hirobe M
    Drug Metab Dispos; 1991; 19(1):257-62. PubMed ID: 1673411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline binds with tubulin beta, a substrate of parkin, and reduces its polyubiquitination.
    Kohta R; Kotake Y; Hosoya T; Hiramatsu T; Otsubo Y; Koyama H; Hirokane Y; Yokoyama Y; Ikeshoji H; Oofusa K; Suzuki M; Ohta S
    J Neurochem; 2010 Sep; 114(5):1291-301. PubMed ID: 20067570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of a novel neurotoxic metabolite of Parkinson's disease-related neurotoxin, 1-benzyl-1,2,3,4- tetrahydroisoquinoline.
    Kotake Y; Sekiya Y; Okuda K; Ohta S
    J Toxicol Sci; 2014; 39(5):749-54. PubMed ID: 25242405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ), an endogenous neurotoxin, induces dopaminergic cell death through apoptosis.
    Shavali S; Ebadi M
    Neurotoxicology; 2003 Jun; 24(3):417-24. PubMed ID: 12782106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and neurotoxicity of tetrahydroisoquinoline derivatives for studying Parkinson's disease.
    Abe K; Saitoh T; Horiguchi Y; Utsunomiya I; Taguchi K
    Biol Pharm Bull; 2005 Aug; 28(8):1355-62. PubMed ID: 16079473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro cytotoxicity of 1,2,3,4-tetrahydroisoquinoline derivatives.
    Saitoh T; Abe K; Ishikawa M; Nakatani M; Shimazu S; Satoh N; Yoneda F; Taguchi K; Horiguchi Y
    Eur J Med Chem; 2006 Feb; 41(2):241-52. PubMed ID: 16412536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of 1-methyl-1,2,3,4-tetrahydroisoquinoline-synthesizing enzyme from rat brain: a possible Parkinson's disease-preventing enzyme.
    Yamakawa T; Ohta S
    Biochem Biophys Res Commun; 1997 Jul; 236(3):676-81. PubMed ID: 9245712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of tetrahydroisoquinoline and 1-methyl-tetrahydro-isoquinoline in foods: compounds related to Parkinson's disease.
    Makino Y; Ohta S; Tachikawa O; Hirobe M
    Life Sci; 1988; 43(4):373-8. PubMed ID: 3398705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous parkinsonism-inducing toxin, strongly potentiates MAO-dependent dopamine oxidation and impairs dopamine release: ex vivo and in vivo neurochemical studies.
    Wasik A; Romańska I; Antkiewicz-Michaluk L
    Neurotox Res; 2009 Jan; 15(1):15-23. PubMed ID: 19384584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capillary liquid chromatography-tandem mass spectrometry of tetrahydroisoquinoline derived neurotoxins: a study on the blood-brain barrier of rat brain.
    Song Y; Xu J; Hamme A; Liu YM
    J Chromatogr A; 2006 Jan; 1103(2):229-34. PubMed ID: 16310796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.